Bibliography

  1. Abramson, J. (2004). Overdosed America. New York: Harper Collins.
  2. Aminorroaya, A., Kelleher, S., Conway, A.J, Ly, L.P., & Handelsman, D.J. (2005). Adequacy of androgen replacement influences bone density response to testosterone in androgen    deficient men. European Journal of Endocrinology, 152, 881-886.
  3. Amory, J.K., Watts, N.B., Easley, K.A., Sutton, P.R., Anawalt, B.D., Matsumoto, A.M., Bremner, W.J., & Tenover, J.L. (2004). Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone Levels.vThe Journal of Clinical Endocrinology, 89(2), 503-510.
  4. Araujo, A.B., Dixon, J.M., Suarez, E.A., Murad, H.M., Guey, L.T. & Wittert, G.A. (2011).  Clinical Review: Endogenous Testosterone and Mortality in Men: A Systematic review  and Meta-Analysis. Journal of Clinical Endocrine Metabolism, 96(10), 1-13.
  5. Armstrong, N., Hearnshaw, H., Powell, J., & Dale, J. (2007). Stakeholder Perspectives on the Development of a Virtual Clinic for Diabetes Care: Qualitative Study. Journal of Medical Internet Research, 9(3), e23. doi:10.2196/jmir.9.3.e23
  6. Astin, J.A. (1998). Why Patients Use Alternative Medicine. JAMA, 279(19), 1548-1553.
  7. Bachmann, G.A.(1999). Androgen co-therapy in menopause: Evolving benefits and challenges. American Journal of Obstetrics and Gynecology, 180(3), 308-311.
  8. Barrett-Conner, E., Dam, T.T., Stone, K., Harrison, S.L., Redline, S. & Orwoll, E. (2008). The     Association of Testosterone Levels with Overall Sleep Quality, Sleep Architecture, and Sleep-Disordered Breathing. Journal of Clinical Endocrine Metabolism, 93(7), 2602-2609.
  9. Bialek, M., Zaremba, P., Borowicz, K.K., Czuczwar, S.J. (2004). Neuroprotective role of testosterone in the nervous system. Polish Journal of Pharmacology, 56, 509-518.
  10. Bayer, U. & Hausmann, M. (2011). Sex Hormone Therapy and Functional Brain Plasticity in Postmenopausal Women. Neuroscience, 191, 118-128.
  11. Beuachet, O. (2006). Testosterone and cognitive function: Current clinical evidence of a relationship. European Journal of Endocrinology, 155, 773-781.
  12. Boyanov, M.A., Boneva, Z., & Christov, V.G. (2003). Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. The Aging Male, 6, 1-7.
  13. Carnahan, R.M.& Perry, P.J. (2004). Depression in Aging Men: The role of testosterone. Aging   Drugs, 21(6), 361-376.
  14. Cherrier, M.M., Asthana, S., Plymate, S., Baker, L., Matsumoto, A.M., Peskind, E., Raskind,  M.A., Brodkin, K., Bremner, W., Petrova, A., LaTendresse, S., & Craft, S. (2001).   Testosterone supplementation improves spatial and verbal learning memory in healthy older men. Neurology, 57, 80-88.
  15. Cobb, J. (n.d.). How much does it cost to create eLearning? Retrieved on November 5, 2016 from: http://www.tagoras.com/cost-to-create-e-learning/
  16. Davis, S. (1999). Androgen replacement in women: A commentary. Journal of Clinical      Endocrinology and Metabolism, 84(6), 1886-1891.
  17. Davis, S.R. &Tran, J. (2001). Testosterone influences libido and well being in women. Trends in Endocrinology and Metabolism, 12(1), 33-37.
  18. Davison, S.L., Bell. R.J., Gavrilescu, M., Searle, K., Maruff, P., Gogos, A., Rossell, S.L., Adams, J., Egan, G.F., & Davis, S.R. (2011). Testosterone improves verbal learning and memory in postmenopausal women: Results from a pilot study. Maturitas, 70, 307-311.
  19. Dimitrakakis, C. (2011). Androgens and Breast Cancer in Men and Women. Journal:       Endocrinology Metabolism Clinics of North America, 40, 533-537.
  20. Dimitrakakis, C. & Bondy, C. (2009). Androgens and the breast. Breast Cancer Research, 11(5), 212. doi:10,1186/brc2413.
  21. Dimitrakakis, C., Jones, R.A., Liu, A., & Bondy, C.A. (2004). Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy.       Menopause: The Journal of the North American Menopause Society, 11(5), 531-535.
  22. Dimitrakakis, C., Zhou, J., Wang, J., Belanger, A., LaBrie, F., Cheng, C., Powell, D. & Bondy, C. (2003). A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause: The Journal of the North American Menopause Society, 10(4), 292-298.
  23. DiSaia, P.J., Grosen, E.A., Kurosaki, T., Gildea, M., Cowan, B. & Anton-Culver, H. (1996). Hormone replacement therapy in breast cancer survivors: A cohort study. American Journal of Obstetrics & Gynecology, 174(5), 1494-1498.
  24. Durna, E.M., Heller, G.Z., Leader, L.R., Sjoblom, P., Eden, J.A., & Wren, B.G. (2004). Breast cancer in premenopausal women: recurrence and survival rates and relationship to hormone replacement therapy. Climacteric, 7, 284-291.
  25. Durna, E.M., Wren, B.G., Heller, G.Z., Leader, L.R., Sjoblom, P., & Eden, J.A. (2002). Hormone replacement therapy after a diagnosis of breast cancer: cancer recurrence and mortality. Medical Journal of Australia, 177, 347-351. doi:10.1016/j.maturitas.2010.12.001
  26. Ebinger, M., Sievers, C., Ivan, D., Schneider, H.J., & Stalla, G.K. (  2009). Is there a         neuroendocrinological rationale for testosterone as a therapeutic option for depression?  Journal of Psychopharmacology, 23(7), 841-853.
  27. Eigeliene, N., Elo, T., Linhala, M., Hurme, S., Erkkola, R., & Harkonen, P. (2012). Androgens Inhibit the Stimulatory Action of 17beta-Estradiol on Normal Human Breast Tissue in Explant Cultures. Journal of Clinical Endocrine Metabolism, 97(7), 1-12.
  28. Feldstein, A.C., & Glasgow, R.E. (2008). A Practical, Robust Implementation and Sustainability Model (PRISM) for Integrating Research Findings into Practice. Joint Commission on  Accreditation of Healthcare Organizations, 34(4), 228-243.
  29. Fugh-Berman, A. & Bythrow, J, (2007). Bio-identical Hormones for Menopausal Hormone Therapy: Variation of a Theme. JGIM: Journal of General Internal Medicine, 22, 1030- 1034.
  30. Glaeser, E.L. & Schleifer, A. (2001). Not-for-profit Entrepreneurs. Journal of Public Economics, 81, 99-115.
  31. Glaser, R., Dimitrakakis, C., Trimble, N., & Martin, V. (2012). Testosterone pellet implants and migraine headaches: A pilot study. Maturitas, doi:10.1016/j.maturitas.2012.01.006.
  32. Glaser, R., York, A.E., & Dimitrakakis, C. (2010). Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS). Maturitas, doi:10.1016/j.maturitas.2010.12.001.
  33. Goldenberg, I.S. (1964). Testosterone Proionate Therapy in Breast Cancer. JAMA, 188(12). 117- 120.
  34. Greenberg, P. (2015). The growing economic burden of depression in the U.S. Scientific     American Online Journal. Retrieved on Nov 19, 2016 from:             https://blogs.scientificamerican.com/mind-guest-blog/the-growing-economic-burden-of- depression-in-the-u-s/
  35. Hammond, J., Le., Q., Goodyer, C., Gelfand, M., Trifiro, M., & LeBlanc, A. (2001).         Testosterone-mediated neuroprotection through androgen receptor in human primary neurons. Journal of Neurochemistry, 77, 1319-1326.
  36. Healthy People 2020. Foundation Health Measure Report: Health Related Quality of Life and     Well-Being. Retrieved from: http://www.healthypeople.gov/sites/default/files/HRQoLWBFullReport.pdf
  37. Hofling, M., Hirschberg, A.L., Skoog, L., Tani, E., Hagerstrom, T. & von Schultz, B. (2007). Testosterone inhibits estrogen/progestogen induced breast cell proliferation in postmenopausal women. Menopause: The Journal of the North American Menopause       Society, 14(2), 1-8.
  38. Isodori, A.M., Gianetta, E., Greco, E.A., Gianfrilli, D., Bonifacio, V., Isidori, A., Lenzit, A., &     Fabbri, A. (2005). Effects of testosterone on body composition, bone, metabolism, and serum lipid profile in middle aged men: A meta-analysis. Clinical Endocrinology, 63, 280-293.
  39. Kautz, H.D. & DeNosaquo, N. (1960). Report to the Council: Androgens and estrogens in the treatment of disseminated mammary carcinoma. JAMA, 172(12), 135-172.
  40. Kritsonis, A. (2005). Comparison of change theories. International journal of scholarly    academic intellectual diversity, 8(1), 1-7.
  41. Loesner, A.A. (1954). A New Therapy for Prevention of Post-operative Recurrences in Genital   and Breast Cancer: A six-years study of prophylactic thyroid treatment. BMJ: British  Medical Journal, December, 1380-1383.
  42. Magrath, A.J. (1986). When Marketing Services, 4 P’s Are Not Enough. Business Horizons, May-June, 44-50.
  43. Nappi, R.E. & Lachowsky, M. (2009). Menopause and sexuality: Prevalence of symptoms and   impact on quality of life. Maturitas, 63, 138-141.
  44. Okun, M.S., Walter, B.L., McDonald, W.M., Tenover, J.L., green, J., Juncos, J.L., & DeLong,  M.R. (2002). Beneficial Effects of Testosterone Replacement for the Non-motor  Symptoms of Parkinson’s Disease. Archives of Neurology, 59, 1750-1753.
  45. Patsner, Bruce (2008). Pharmacy Compounding of Bio-identical Hormone Replacement Therapy (BHRT): A Proposed New Approach to Justify FDA Regulation of These Prescription Drugs. Food & Drug Law Journal, 63, 459. Retrieved from:            http://heinonline.org/HOL/LandingPage?handle=hein.journals/foodlj63&div=28&id=&pa       ge=
  46. Pike, C., Carroll, J.C., Rosario, E.R., & Barron, A.M. (2009). Protective actions of sex steroid      hormones in Alzheimer’s disease. Frontiers in Neuroendocrinology, 30, 239-258.
  47. Pilzer, P. Z. (2002). The wellness revolution: How to make a fortune in the next trillion-dollar industry. New York: John Wiley and Sons.
  48. Rosenberg, W. & Donald, A. (1995). Evidence based medicine: An approach to clinical problem   solving. BMJ: British Medical Journal, 310, 1122-1126.
  49. Sands, R. & Studd, J. (1995). Exogenous Androgens in Postmenopausal Women. The American    Journal of Medicine, 98(1A), 76-79.
  50. Somboonporn, W. & Davis, S. (2004). Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women. Endocrine Reviews, 25(3), 374-388.
  51. Somboonporn, W. & Davis, S. (2004). Postmenopausal testosterone therapy and breast cancer     risk. Maturitas, 49, 267-275.
  52. Staa, T.P., & Sprafka, J.M. (2009). Study of adverse outcomes in women using testosterone therapy. Maturitas, 62, 76-80.
  53. Studd, J & Panay, N. (2004). Hormones and depression in women. Climacteric, 7, 338-346.
  54. Unknown Author (1946). Testosterone in the treatment of advanced carcinoma of the breast. JAMA, 131(7), 1425. Downloaded from http://www.jama.com.
  55. Vanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M.K., Bouillon, R., & Ohlsson, C. (2004). Androgens and Bone. Endocrine Reviews, 25(3), 389-425.
  56. van Geel, T., Geusnes, P.P., Winkens, B., Sels, J.J., & Dinant, G.J. (2009). Measures of   bioavailable serum testosterone an estradiol and their relationship with muscle mass, muscle strength, and bone mineral density in postmenopausal women: A cross-sectional   study. European Journal of Endocrinology, 160, 681-687.
  57. Wilson, I.B.,& Cleary, P.D. (1995). Linking Clinical Variables with Health Related Quality of Life. JAMA, 273, (1), 59-65.